Cigna Aktie News

The Cigna Group (CI) Q4 2025 Earnings Call Transcript

The Cigna Group stands out as a deeply undervalued healthcare pick, trading at a forward P/E of 9 versus a 10-year average of 13.5. CI targets 10–14% annual adjusted EPS growth long-term, driven by customer growth, pricing, acquisitions, and share repurchases. The stock offers a 2.2% dividend yield with a low payout ratio, supporting continued double-digit dividend growth and a Chowder number n...

Cigna Group logged higher revenue in its latest quarter as its pharmacy-benefit business Evernorth continues to grow.

The Cigna Group Thursday reported 2025 net income of nearly $6 billion despite grappling with rising costs of patients in the health insurance plans it sells and administers.

Cigna on Thursday forecast 2026 profit and revenue below Wall Street expectations, signaling continued medical cost and margin pressure.

Total revenues for 2025 increased 11% to $274.9 billion Shareholders' net income for 2025 was $6.0 billion, or $22.18 per share Adjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share 2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2 Board of Directors declared an increase in the quarterly dividend to $1.56 pe...

Tables begin to turn on PBM after years of squeezing consumers, employers, and independent pharmacies Tables begin to turn on PBM after years of squeezing consumers, employers, and independent pharmacies

Cigna Corp's Express Scripts has settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies, according to a copy of the settlement seen by Reuters.